Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

<p>Abstract</p> <p>Background</p> <p>Hypofractionated stereotactic body radiation therapy (SBRT) has been advanced as monotherapy for low-risk prostate cancer. We examined the dose distributions and early clinical outcomes using this modality for the treatment of interm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ju Andrew W, Wang Hongkun, Oermann Eric K, Sherer Benjamin A, Uhm Sunghae, Chen Viola J, Pendharkar Arjun V, Hanscom Heather N, Kim Joy S, Lei Siyuan, Suy Simeng, Lynch John H, Dritschilo Anatoly, Collins Sean P
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2013-01-01
Saila:Radiation Oncology
Gaiak:
Stereotactic body radiotherapy
Prostate cancer
SBRT
CyberKnife
Intermediate-risk
Monotherapy
Hypofractionation
Sarrera elektronikoa:http://www.ro-journal.com/content/8/1/30
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak